Abhiram Prasad, M.D., and Joerg Herrmann, M.D. N Engl J Med 2011; 364:453-464February 3, 2011
Approximately 1.5 million patients undergo percutaneous coronary intervention (PCI) in the United States every year.1 Depending on local practices and the diagnostic criteria used, 5 to 30% of these patients (75,000 to 450,000) have evidence of a periprocedural myocardial infarction.2,3 At the higher estimate, the incidence of these events is similar to the annual rate of major spontaneous myocardial infarction.1
Thus, many cardiologists and internists are likely to encounter patients with coronary artery disease who have sustained a periprocedural myocardial infarction. However, the clinical significance of these events and their management remain a matter of considerable controversy and uncertainty . . .
Weblink here